Trial intelligence / Profile preview

Dornase Alfa for Mechanical Ventilation Duration (LUFIT)

NCT00204685Phase 3Unknown

Sponsor
University Hospital Tübingen
Start
Aug 2003
Modality
Replacement Enzymes
Countries
1
01

Overview

A Phase 3 trial of dornase alfa in respiratory failure, atelectasis, sponsored by University Hospital Tübingen. Status: unknown.

02

Drugs

dornase alfa
03

Conditions

respiratory failureatelectasis

Beyond the preview

Go deeper on NCT00204685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00204685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call